Flossbach Von Storch Ag Bio N Tech Se Transaction History

Flossbach Von Storch Ag

$25.3 Billion
Q3 2024

A detailed history of Flossbach Von Storch Ag transactions in Bio N Tech Se stock. As of the latest transaction made, Flossbach Von Storch Ag holds 4,359,607 shares of BNTX stock, worth $493 Million. This represents 2.05% of its overall portfolio holdings.

Number of Shares

4,359,607

Previous 4,379,483 0.45%

Holding current value

$493 Million

Previous $352 Million 47.13%

% of portfolio

2.05%

Previous 1.49%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$78.36 - $124.66 $1.56 Million - $2.48 Million	-19,876 Reduced 0.45%	4,359,607 $518 Million
Q2 2024 Aug 02, 2024	BUY	$80.36 - $102.87 $73.2 Million - $93.7 Million	910,497 Added 26.25%	4,379,483 $352 Million
Q1 2024 May 06, 2024	SELL	$88.96 - $112.35 $7.09 Million - $8.95 Million	-79,674 Reduced 2.25%	3,468,986 $320 Million
Q4 2023 Jan 31, 2024	BUY	$90.91 - $112.75 $3.22 Million - $4 Million	35,445 Added 1.01%	3,548,660 $375 Million
Q3 2023 Oct 27, 2023	BUY	$98.5 - $125.08 $7.04 Million - $8.94 Million	71,468 Added 2.08%	3,513,215 $382 Million
Q2 2023 Aug 02, 2023	BUY	$102.58 - $129.66 $965,585 - $1.22 Million	9,413 Added 0.27%	3,441,747 $371 Million
Q1 2023 May 03, 2023	BUY	$122.57 - $153.67 $18.3 Million - $23 Million	149,611 Added 4.56%	3,432,334 $428 Million
Q4 2022 Feb 06, 2023	SELL	$118.43 - $186.05 $9.69 Million - $15.2 Million	-81,841 Reduced 2.43%	3,282,723 $493 Million
Q3 2022 Nov 14, 2022	BUY	$127.65 - $183.11 $38.2 Million - $54.8 Million	299,414 Added 9.77%	3,364,564 $454 Million
Q2 2022 Aug 10, 2022	BUY	$123.25 - $186.24 $141 Million - $213 Million	1,145,061 Added 59.64%	3,065,150 $457 Million
Q1 2022 May 11, 2022	BUY	$126.25 - $231.85 $242 Million - $445 Million	1,920,089 New	1,920,089 $327 Million

Others Institutions Holding BNTX

# of Institutions

357

Shares Held

38.3M

Call Options Held

2.45M

Put Options Held

2.29M

View Full List

About BioNTech SE

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $27.4B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

More about BNTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Flossbach Von Storch Ag, based on Form 13F filings with the SEC.

News

Stay updated on Flossbach Von Storch Ag with notifications on news.

Account

Flossbach Von Storch Ag Bio N Tech Se Transaction History